Nammi Therapeutics Inc
1 clinical trials · Sponsor
◉ Watch Nammi Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma (NCT06582017) | Nammi Therapeutics Inc | 2024-08-28 |
Track Nammi Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.